GPO signs vaccine pact with Korean biotech giant

Signing the memorandum of understanding on collaboration on vaccines for Thai public health security on Tuesday, from left: Dr Mingkhwan Suphanpong, director of the Government Pharmaceutical Organization (GPO); Dr Opas Karnkawinpong, GPO chairman and permanent secretary of the Ministry of Public Health; Jeon Jo-young, charge d’affaires of the South Korean Embassy in Thailand; and Ahn Jae-yong, CEO of SK bioscience. (Photo: GPO)

The Government Pharmaceutical Organization (GPO) has bolstered its partnership with SK bioscience of South Korea to enhance regional vaccine security, starting with the production of influenza vaccines scheduled for availability next year.

The cooperation is outlined in a memorandum of understanding signed on Tuesday by GPO representatives, led by director Dr Mingkhwan Suphanpong, and SK bioscience under the leadership of president and CEO Ahn Jae-yong.